Senova Technology Co., Ltd.

+86-0755-3337-2138/2139

info@senovatech.com

Home

About

Product

Service

News

Join

Contact

Home

About

Product

APIs

Anti-Viral

Anti-Infection

Anti-Bacteria

Anti-Coagulants

Anti-Cancer

Advance Intermediates

Peptides

Fine Chemicals

Others

Service

News

Company news

Industry news

Company statement

Join

Contact

LNK

TOP

WE USE COOKIES ON OUR WEBSITE

This website uses Cookies to help improve your user experience.

MAYBE LATER

look over

I AGREE

Step With Innovation!

Empowering Innovation in
Pharmaceuticals - APIs, Peptides,
Key Intermediates and CDMO Solutions

Senova Technology Co., Ltd. is a leading/professional supplier for APIs/Peptides/Key
Intermediates/CDMO service with GMP and ISO approved facilities.

Learn more

Who are we?

We are a Leading Pharmaceutical Supplier Company

Senova Technology Co., Ltd. is a leading ISO/GMP approved company for APIs/Peptides/Key Intermediates/CDMO service business since 2013! Based on our headquarter in Shenzhen, high-level R&D center in Hangzhou and FDA approved facility in Chenggu of Shanxi province, we supply products with reliable quality, international regulations and full documents support!

Years of establishment

1300

Number of customer

Number of exporting countries

220

Total employees

What we provide

Products & Services

We supply products with reliable quality, international regulations and full documents support!

Recommended

Products

Services

JAK Inhibitors series

Medications that target Janus kinase enzymes to treat inflammatory and autoimmune diseases.

Anti-diabetes Series

Medications that help manage diabetes by lowering blood sugar levels, improving insulin sensitivity, and/or increasing insulin production.

Amino Acid Series

Essential building blocks of proteins that play key roles in various biological processes, including Pharmaceutical Grade and Food/Feed Grade.

Semaglutide

A GLP-1 receptor agonist used for the treatment of type 2 diabetes, helping to lower blood sugar levels and promote weight loss.

APIs

Active pharmaceutical ingredients used in the production of therapeutic drugs.

Advanced Intermediates

Synthesizes basic compounds for pharmaceutical products.

Peptides & Amino Acid

Short chains of amino acids with various biological uses.

Others

High-quality specialty chemicals for different industrial applications.

CMO/CDMO Services

Comprehensive Contract Manufacturing (CMO) and Development (CDMO) services, offering tailored solutions for pharmaceutical development and manufacturing needs.

DMF/CMC/SMF Preparation

Efficient preparation of Drug Master Files (DMF), Chemistry, Manufacturing, and Controls (CMC), and Site Master Files (SMF) for regulatory compliance.

Pre-Audit/Audit

Conducting thorough pre-audits and audits to ensure regulatory compliance and adherence to quality standards in pharmaceutical processes.

Document Translation/Audit

Accurate translation services for pharmaceutical documents and audit reports, facilitating seamless communication in the global regulatory landscape.

Quality&Compliance

Comply with international
standards and regulations

20 Invention Patents

15 Certificates Held

EIR

Our EIR (Establishment Inspection Report) approved by U.S. Food and Drug Administration

ISO

Quality management system certificate conforms to ISO9001:2015 Pharmaceutical materials sales

CEP

EDQM Certificate of Suitability to monograph of European Pharmacopeia

GMP

Good Manufacturing Practice of Medical Products(GMP) Regulations (EU-GMP/ CEP/ FDA EIR/ Chinese GMP) for APIs

Where our partners from?

Our Partners Spread All Over The World

Our global reach and extensive partner network showcase our ability to meet the diverse demands of the pharmaceutical industry on a worldwide scale.

Number of exporting countries

1300

Number of customer

Europe

Gained trust in countries such as the UK, Germany, France, Italy, Spain, and others

Middle East and Africa

Established valued partnerships with partners across the Middle East and African countries

Latin America

Commitment extends to partners in countries like Brazil, Argentina, Colombia, and Chile

Asia

We serve partners in countries including Japan, India, South Korea, Australia, and others

America

Mexico

Colombia

Argentina

Brazil

Spain

Algeria

Tunisia

Italy

Nigeria

South Africa

Saudi Arabia

United Arab Emirates

India

Russia

Vietnam

South Korea

Japan

Australia

News Information

Share with you the latest
cutting-edge information

Company news

AII NEWS

Participating in CPHI Worldwide Milan to Showcase Company Goals and Vision

2024-10-21

Participating in CPHI Worldwide Milan to Showcase Company Goals and Vision

Senova to Attend CPHI Worldwide in Milan

2024-08-23

SenovaTech Team Triumphs at CPHI 2024 Shanghai: A Unified and Visionary Journey

2024-06-27

Senova Team to Participate in Visit to CPHI KOREA 2023

2023-09-14

Industry news

AII NEWS

Novo's semaglutide reduced ris

2024-11-05

Novo's semaglutide reduced risk of multiple diseases

Lilly to invest US$ 4.5 bn in

2024-10-12

Lilly to invest US$ 4.5 bn in advanced drug development center in Indiana

Recent news about Eli Lilly and Company

US Biosecure Act to restrict b

2024-09-18

US Biosecure Act to restrict business with Chinese firms passes House

Novo's weight-loss drug Saxend

2024-09-18

Novo's weight-loss drug Saxenda found to be safe, effective at reducing Bll of kids

How to choose between semaglut

2024-09-06

How to choose between semaglutide and tirzepatide

Learn more about Tirzepatide

2024-09-06

Learn more about Tirzepatide

GLP-1 drug shortages create US

2024-09-03

GLP-1 drug shortages create US $1 billion shadow industry

Lilly to sell Zepbound vials d

2024-09-03

Lilly to sell Zepbound vials directly to consumers

Semaglutide Usage and Storage

2024-08-28

Semaglutide Usage and Storage Methods

Semaglutide is a revolutionary

2024-08-27

Semaglutide is a revolutionary product in the weight loss market

US court rules for AstraZeneca

2024-08-20

US court rules for AstraZeneca, erasing Pfizer's $107.5M jury award in patent infringement case

Zealand Pharma seeks big pharm

2024-08-16

Zealand Pharma seeks big pharma partners for obesity drug candidate

Lilly, Novo Nordisk battle for

2024-08-07

Lilly, Novo Nordisk battle for weight-loss market lands at the pharmacy shelf

Weight loss drug's trial resul

2024-08-02

Results from a phase 2b clinical trial in the UK have shown that Novo Nordisk's GLP-1drug liraglutide can protect the brain against dementia.

PHARMA Novo Nordisk posts 'bes

2023-08-10

Novo Nordisk has been riding the momentum of weight loss drug Wegovy ever since it stormed onto the market in 2021, creating widespread hype and even some supply shortfalls. But, now, a cardio outcomes trial could seriously change the game for the burgeoning medicine.